Profile data is unavailable for this security.
About the company
Hoya Corp is a Japan-based company engaged in the manufacture and sale of healthcare-related products, medical-related products, electronics-related products, and imaging-related products, as well as related businesses. The Company operates in three business segments. The Life Care segment manufactures and sells healthcare-related products used in daily life in the health and medical fields, and medical-related products such as medical devices and medical supplies used in medical procedures. The Information and Communication segment manufactures and sells components essential for digital equipment, including electronics-related products that are indispensable for modern digital information and communication technology and imaging-related products that are necessary for capturing images and video as digital information based on optical technology. The Others segment is mainly engaged in the speech synthesis software business and the information system services business.
- Revenue in USD (TTM)6.00bn
- Net income in USD1.64bn
- Incorporated1944
- Employees--
- LocationHoya Corp20F, Nittochi Nishishinjuku Bldg., 6-10-SHINJUKU-KU 160-8347JapanJPN
- Phone+81 369114811
- Websitehttps://www.hoya.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Waters Corp | 3.17bn | 642.63m | 31.72bn | 7.60k | 30.04 | 12.38 | 37.35 | 10.02 | 10.77 | 10.77 | 53.03 | 26.11 | 0.6569 | 2.46 | 4.05 | -- | 13.34 | 17.03 | 14.53 | 20.68 | 59.28 | 59.01 | 20.30 | 22.40 | -- | 16.77 | 0.3546 | -- | 6.99 | 6.00 | 0.7518 | 4.26 | -8.14 | -- |
| Agilent Technologies Inc | 6.95bn | 1.30bn | 35.58bn | 18.10k | 27.56 | 5.28 | 22.37 | 5.12 | 4.56 | 4.56 | 24.34 | 23.82 | 0.5655 | 3.29 | 4.94 | 383,867.40 | 10.61 | 11.44 | 12.82 | 13.67 | 52.73 | 53.25 | 18.75 | 18.82 | 1.52 | 18.30 | 0.3322 | 20.76 | 6.73 | 5.41 | 1.09 | 12.63 | 27.88 | 7.10 |
| GE HealthCare Technologies Inc | 20.63bn | 2.09bn | 36.61bn | 54.00k | 17.65 | 3.53 | 13.40 | 1.78 | 4.55 | 4.55 | 45.03 | 22.77 | 0.5893 | 5.93 | 4.31 | 381,944.40 | 6.15 | 6.70 | 8.46 | 9.25 | 39.98 | 40.44 | 10.44 | 10.49 | 1.13 | 9.97 | 0.4866 | 1.85 | 4.84 | 3.74 | 4.57 | 0.7558 | 13.23 | -- |
| Resmed Inc | 5.40bn | 1.49bn | 36.79bn | 10.60k | 24.96 | 5.82 | 21.76 | 6.82 | 10.12 | 10.12 | 36.75 | 43.39 | 0.6901 | 2.34 | 5.53 | 509,256.50 | 19.00 | 15.33 | 21.94 | 17.76 | 60.85 | 57.29 | 27.53 | 21.96 | 2.32 | -- | 0.095 | 28.94 | 9.84 | 11.72 | 37.20 | 17.64 | -1.02 | 1.69 |
| Edwards Lifesciences Corp | 6.07bn | 1.06bn | 44.03bn | 15.80k | 42.00 | -- | 39.82 | 7.26 | 1.81 | 1.83 | 10.36 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 78.01 | 79.39 | 17.40 | 24.79 | -- | -- | -- | -- | 11.55 | 6.70 | -24.33 | 5.18 | -- | -- |
| Becton Dickinson and Co | 21.92bn | 1.76bn | 50.08bn | 72.00k | 28.75 | 1.98 | 11.85 | 2.28 | 6.12 | 6.12 | 76.34 | 88.79 | 0.4004 | 2.96 | 8.52 | 304,500.00 | 3.21 | 3.00 | 3.78 | 3.48 | 46.42 | 45.58 | 8.01 | 8.20 | 0.5826 | 6.68 | 0.4359 | 66.89 | 8.24 | 6.32 | -1.58 | 46.93 | -0.2352 | 5.65 |
| IDEXX Laboratories Inc | 4.30bn | 1.06bn | 50.25bn | 11.00k | 48.12 | -- | 54.76 | 11.68 | 13.08 | 13.08 | 53.12 | -- | -- | -- | -- | 391,245.60 | -- | 28.96 | -- | 43.58 | 61.80 | 60.30 | 24.62 | 22.86 | -- | 37.95 | -- | -- | 10.42 | 9.72 | 19.33 | 12.74 | 2.94 | -- |
| Medline Inc | 27.43bn | 1.27bn | 58.53bn | 24.00k | 46.23 | 3.41 | 27.57 | 2.13 | 0.9637 | 0.9637 | 20.88 | 13.05 | -- | -- | -- | 1,142,875.00 | -- | -- | -- | -- | 27.18 | -- | 4.62 | -- | 1.84 | 2.68 | 0.4917 | -- | 9.80 | -- | 412.82 | -- | -- | -- |
| Hoya Corp (ADR) | 6.00bn | 1.64bn | 62.35bn | -- | 38.33 | 9.25 | 31.42 | 10.39 | 4.80 | 4.80 | 17.54 | 19.90 | 0.7091 | 0.9534 | 4.94 | -- | 19.24 | -- | 22.58 | -- | 86.26 | -- | 27.13 | -- | 4.27 | -- | 0.0383 | -- | 13.56 | -- | 11.43 | -- | -- | -- |
| Cencora Inc | 325.78bn | 1.63bn | 70.19bn | 51.00k | 43.40 | 36.78 | 26.08 | 0.2155 | 8.31 | 8.31 | 1,671.64 | 9.81 | 4.42 | 14.08 | 12.21 | 6,387,800.00 | 2.23 | 2.64 | 9.81 | 11.63 | 3.63 | 3.38 | 0.5035 | 0.6038 | 0.5086 | 11.82 | 0.7908 | 24.98 | 9.31 | 11.09 | 2.99 | -- | 12.56 | 5.79 |
| Holder | Shares | % Held |
|---|---|---|
| Boston Common Asset Management LLCas of 31 Dec 2025 | 49.92k | 0.02% |
| Goldman Sachs Asset Management LPas of 31 Oct 2025 | 48.29k | 0.01% |
| Eagle Global Advisors LLCas of 30 Sep 2025 | 34.00k | 0.01% |
| Causeway Capital Management LLCas of 05 Feb 2026 | 20.62k | 0.01% |
| Ramirez Asset Management, Inc.as of 31 Dec 2025 | 18.40k | 0.01% |
| BPI Gest�o de Activos SGOIC SAas of 30 Jun 2025 | 9.44k | 0.00% |
| RhumbLine Advisers LPas of 31 Dec 2025 | 8.15k | 0.00% |
| Yousif Capital Management LLCas of 31 Dec 2025 | 3.65k | 0.00% |
| BlackRock Advisors LLCas of 05 Feb 2026 | 3.38k | 0.00% |
| ShariaPortfolio, Inc.as of 05 Feb 2026 | 2.14k | 0.00% |
